EUVIMEDEUVIMED entdecken
Kohortenstudie

Limited lymph node examination and survival among node-negative non-metastatic breast cancer patients: a SEER-based retrospective cohort study

Fang Zhao, Ran Ju, Zhen Ma, Lihui Yang, Li Yang, Shuqun Zhang, Bing Lei

Gland Surgery · 2026-01 · ---

DOI: 10.21037/gs-2026-0376 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Gland Surgery, 2026-01. Verfasst von Fang Zhao und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sentinel lymph node biopsy (SLNB) is widely used for axillary staging in breast cancer, but the number of lymph nodes examined varies in practice. In patients classified as T1–4N0M0, whether a negative nodal status based on only one examined node provides sufficient staging confidence remains unclear. This study aimed to investigate the association between the number of examined regional lymph nodes and survival outcomes in patients with node-negative, non-metastatic breast cancer.

Methods

Female patients with primary T1–4N0M0 non-metastatic breast cancer diagnosed between 2000 and 2021 were included if they underwent surgery and had 1–5 regional lymph nodes examined. Patients with nodal involvement, distant metastasis, no or unknown surgery, no examined nodes, six or more examined nodes, missing survival information, or diagnosis by death certificate/autopsy only were excluded. Patients were grouped as 1, 2–3, or 4–5 examined nodes. Overall survival (OS) was analyzed using Kaplan-Meier analysis and multivariable Cox regression adjusted for age, race, hormone receptor status, human epidermal growth factor receptor 2 (HER2) status, marital status, histological type, grade, T stage, radiotherapy, and chemotherapy. Breast cancer-specific death was evaluated using Fine-Gray competing-risk analysis.

Results

A total of 504,532 patients were included: 159,889 (31.6%) had 1 node examined, 248,770 (49.3%) had 2–3 nodes examined, and 95,873 (19.1%) had 4–5 nodes examined. The 1-node group had a higher proportion of patients aged >55 years, whereas the 4–5-node group included more younger patients, T2/T3–4 disease, higher grade, and chemotherapy use. Compared with 1 node, 2–3 nodes [hazard ratio (HR), 0.910; 95% confidence interval (CI): 0.886–0.935] and 4–5 nodes (HR, 0.909; 95% CI: 0.877–0.942) were associated with better OS. The association appeared more evident in patients aged ≤55 years and those with T1–2 disease, with a similar pattern for breast cancer-specific death.

Conclusions

In T1–4N0M0 non-metastatic breast cancer, examination of only one regional lymph node was associated with poorer OS and may indicate reduced staging confidence or a higher-risk clinical context, rather than proving that more extensive axillary surgery improves outcomes.

Zitieren

APA

Zhao, F., Ju, R., Ma, Z., Yang, L., Yang, L., Zhang, S., & Lei, B. (2026). Limited lymph node examination and survival among node-negative non-metastatic breast cancer patients: a SEER-based retrospective cohort study. Gland Surgery, 0(0), ---. https://doi.org/10.21037/gs-2026-0376

Vancouver

Zhao F, Ju R, Ma Z, Yang L, Yang L, Zhang S, et al. Limited lymph node examination and survival among node-negative non-metastatic breast cancer patients: a SEER-based retrospective cohort study. Gland Surgery. 2026;0(0):---. doi:10.21037/gs-2026-0376

BibTeX
@article{Zhao2026,
  author = {Zhao, Fang and Ju, Ran and Ma, Zhen and Yang, Lihui and Yang, Li and Zhang, Shuqun and Lei, Bing},
  title = {Limited lymph node examination and survival among node-negative non-metastatic breast cancer patients: a SEER-based retrospective cohort study},
  journal = {Gland Surgery},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {------},
  doi = {10.21037/gs-2026-0376}
}
Kostenlos starten →